The research at Linköping University is already considered a leader both nationally and internationally. In connection with the 2014 evaluation of research in the Faculty of Health Sciences, a special effort in the field of forensic medicine, forensic genetics, and pharmacogenetics was recommended. It could, for example, deal with finding and describing new and dangerous drugs as a cause of poisoning and death, or with identifying genetic variations that could lead to sudden cardiac death.
A field of research in which Linköping University and the National Board of Forensic Medicine have been successful is pharmacogenetics, where genetic causes behind differences in how people react to medicine and poisoning have been in focus.
Last week, the steering group had its première meeting.
“The strategic area will bring together researchers in the field not only in Linköping, but internationally as well. Initially, SEK 2,000,000 a year has been earmarked for the strategic area,” says chairperson Ylva Böttiger, professor of clinical pharmacology.
According to Vice-Chair Henrik Gréen, reader in pharmacogenetics, Linköping University and the National Board of Forensic Medicine are conducting research in the forensic sciences that has already attracted attention.
“This effort gives us the opportunity to further expand and strengthen our profile,” he says.
Åke Hjelm 2016-04-13
Research in forensic sciences get a push forward when Linköping University and the Swedish National Board of Forensic Medicine concentrate on a new strategic area.